IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$472.35 USD
+3.17 (0.68%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $470.94 -1.41 (-0.30%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$472.35 USD
+3.17 (0.68%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $470.94 -1.41 (-0.30%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth F Momentum D VGM
Zacks News
Cynosure (CYNO) Gets CFDA Approval to Market Icon System
by Zacks Equity Research
Cynosure, Inc. (CYNO) announced that it has received clearance from the China Food and Drug Administration (CFDA) to market the Icon Aesthetic System.
Baxter (BAX) Inks Partnership with Americares, Stock Down
by Zacks Equity Research
Baxter International Inc. (BAX) announced a new oral health project in collaboration with Americares, a health-focused relief and development organization.
Varian & Komazawa Establish Radiotherapy Education Center
by Zacks Equity Research
Varian Medical Systems Inc. (VAR) announced a partnership with Komazawa University in Japan to establish an advanced radiotherapy education center equipped with a fully functional Varian TrueBeam medical linear accelerator.